IRCT20210201050197N5招募中未知
Study of bioequivalence of 25 mg Empagliflozin tablets in healthy volunteers after single dose oral administration
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Healthy volunteer
- •Age_18-50 year
排除标准
- •History of liver, kidney and cardiovascular diseases that can affect drug clearance from body
- •History of taking any medication in the last two weeks
- •Creatinine above 2
研究者
相似试验
招募中
Unknown
Bioequivalence study of Empagliflozin 25 mg tabletIRCT20200105046010N83kharazmi company24
已完成
1 期
Bioequivalence of Empagliflozin 25 mg FCT in Healthy Thai volunteersBioequivalence study of 25 mg empagliflozin FCTTCTR20210324005nison Laboratories Co., Ltd.28
招募中
Unknown
Bioequivalence study of Empaglifluzin 25mg tabletIRCT20200105046010N89Faran Pharmed company24
尚未招募
1 期
Bioequivalence study of empagliflozin 25 mg film-coated tablet in Thai healthy volunteersHealthy Thai VolunteersTCTR20230719003Macrophar Co., Ltd.28
尚未招募
1 期
Bioequivalence study of empagliflozin 25 mg film-coated tablet in Thai healthy volunteersThai healthy male and female subjects , Aged 18 to 55 years , BMI were within 18-30 kg/m2 , Good health confirming by physical and clinical.Empagliflozin, Bioequivalence studyTCTR20230711001Faculty of Medicine, Chulalongkorn University28